Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jul 24;83(4):498–505. doi: 10.1054/bjoc.2000.1293

Expression of topoisomerase III α in normal and neoplastic tissues determined by immunohistochemistry using novel monoclonal antibody

A J Lodge 1, J J Anderson 1, S W Ng 3, F Fenwick 2, M Steward 4, B Haugk 1, C H W Horne 4, B Angus 1
PMCID: PMC2374664  PMID: 10945498

Abstract

Topoisomerases are nuclear enzymes that modulate the topological structure of DNA in order to facilitate cellular events such as replication and transcription. These enzymes are also the cellular targets of certain classes of chemotherapeutic agents termed topoisomerase poisons. A new human topoisomerase isoform, IIIa, was discovered in 1996, which is thought to have roles in genome stability and possibly chromosome separation during mitosis. It is possible that novel or existing anti-topoisomerase agents target topoisomerase IIIa, suggesting that this enzyme may have potential as a prognostic marker and chemotherapeutic target. In order to study expression patterns of topoisomerase IIIa we have produced a novel monoclonal antibody to human topoisomerase IIIa (TOPO3a-1A4), and used it to assess topoisomerase IIIa expression in a wide range of normal and neoplastic tissues. We have found that topoisomerase IIIa is expressed in a wide range of tissue types, with especially high concentrations in endothelial cells and stromal fibroblasts. No general relationship was observed between expression of topoisomerase IIIa and proliferation. Expression in neoplastic tissues often paralleled their normal counterparts, although certain tumours showed either increased (e.g. colonic adenoma) or reduced (e.g. gastric carcinoma, small cell carcinoma of bronchus) expression. If topoisomerase IIIa is found to be a target for chemotherapeutic agents, clinical response in different tumour types may be related to topoisomerase IIIa expression, which may be assessed using TOPO3a-1A4. © 2000 Cancer Research Campaign

Keywords: topoisomerase IIIα, monoclonal antibody, expression, immunohistochemistry, tissues

Full Text

The Full Text of this article is available as a PDF (722.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  2. Devine S. M., Larson R. A. Acute leukemia in adults: recent developments in diagnosis and treatment. CA Cancer J Clin. 1994 Nov-Dec;44(6):326–352. doi: 10.3322/canjclin.44.6.326. [DOI] [PubMed] [Google Scholar]
  3. Fisher R. I., Gaynor E. R., Dahlberg S., Oken M. M., Grogan T. M., Mize E. M., Glick J. H., Coltman C. A., Jr, Miller T. P. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993 Apr 8;328(14):1002–1006. doi: 10.1056/NEJM199304083281404. [DOI] [PubMed] [Google Scholar]
  4. Fritz E., Elsea S. H., Patel P. I., Meyn M. S. Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the ataxia-telangiectasia phenotype. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4538–4542. doi: 10.1073/pnas.94.9.4538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gangloff S., McDonald J. P., Bendixen C., Arthur L., Rothstein R. The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol Cell Biol. 1994 Dec;14(12):8391–8398. doi: 10.1128/mcb.14.12.8391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goulaouic H., Roulon T., Flamand O., Grondard L., Lavelle F., Riou J. F. Purification and characterization of human DNA topoisomerase IIIalpha. Nucleic Acids Res. 1999 Jun 15;27(12):2443–2450. doi: 10.1093/nar/27.12.2443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hanai R., Caron P. R., Wang J. C. Human TOP3: a single-copy gene encoding DNA topoisomerase III. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3653–3657. doi: 10.1073/pnas.93.8.3653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kawasaki K., Minoshima S., Nakato E., Shibuya K., Shintani A., Schmeits J. L., Wang J., Shimizu N. One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res. 1997 Mar;7(3):250–261. doi: 10.1101/gr.7.3.250. [DOI] [PubMed] [Google Scholar]
  9. Kudelka A. P., Tresukosol D., Edwards C. L., Freedman R. S., Levenback C., Chantarawiroj P., Gonzalez de Leon C., Kim E. E., Madden T., Wallin B. Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma. J Clin Oncol. 1996 May;14(5):1552–1557. doi: 10.1200/JCO.1996.14.5.1552. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Li W., Wang J. C. Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1010–1013. doi: 10.1073/pnas.95.3.1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ng S. W., Liu Y., Hasselblatt K. T., Mok S. C., Berkowitz R. S. A new human topoisomerase III that interacts with SGS1 protein. Nucleic Acids Res. 1999 Feb 15;27(4):993–1000. doi: 10.1093/nar/27.4.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rothenberg M. L., Eckardt J. R., Kuhn J. G., Burris H. A., 3rd, Nelson J., Hilsenbeck S. G., Rodriguez G. I., Thurman A. M., Smith L. S., Eckhardt S. G. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol. 1996 Apr;14(4):1128–1135. doi: 10.1200/JCO.1996.14.4.1128. [DOI] [PubMed] [Google Scholar]
  14. Seki T., Seki M., Katada T., Enomoto T. Isolation of a cDNA encoding mouse DNA topoisomerase III which is highly expressed at the mRNA level in the testis. Biochim Biophys Acta. 1998 Mar 9;1396(2):127–131. doi: 10.1016/s0167-4781(97)00192-9. [DOI] [PubMed] [Google Scholar]
  15. Wang J. C. DNA topoisomerases. Annu Rev Biochem. 1996;65:635–692. doi: 10.1146/annurev.bi.65.070196.003223. [DOI] [PubMed] [Google Scholar]
  16. Yamagata K., Kato J., Shimamoto A., Goto M., Furuichi Y., Ikeda H. Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8733–8738. doi: 10.1073/pnas.95.15.8733. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES